[Federal Register: February 3, 1999 (Volume 64, Number 22)]
[Notices]               
[Page 5321]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr03fe99-87]

-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

 
Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission will convene two sub-
committee meetings of the Advisory Committee on the Medical Uses of 
Isotopes as follows: The Diagnostic Sub-Committee Meeting will be held 
on February 23 and 24, 1999; the Therapeutic Sub-Committee meeting will 
be held on February 25 and 26, 1999. Both meetings, which are open to 
the public, will take place at the address provided below. The 
discussions will be focused on resolution of comments received on the 
proposed revision to 10 CFR part 35 (Medical Use of Byproduct Material) 
that was published in the Federal Register for comment on August 13, 
1998 (63 FR 43580). The Diagnostic Sub-Committee will focus on comments 
pertaining to uses of unsealed byproduct material in medicine 
(Secs. 35.100, 35.200, and 35.300). The Therapeutic Sub-Committee will 
focus on comments pertaining to therapeutic uses of sealed sources 
(Secs. 35.400 and 35.600).

DATES: The Diagnostic Sub-Committee meeting will be held on February 
23, 1999, from 8:00 a.m. to 5:00 p.m. and on February 24, 1999, from 
8:00 a.m. to 12:00 p.m. The Therapeutic Sub-Committee meeting will be 
held on February 25, 1999, from 8:00 a.m. to 5:00 p.m. and on February 
26, 1999, from 8:00 a.m. to 12:00 p.m.

ADDRESSES: U.S Nuclear Regulatory Commission, One White Flint North 
Building, 11555 Rockville Pike, Room 04B6, Rockville, MD 20852-2738.

FOR FURTHER INFORMATION CONTACT: Mary Louise Roe, U.S. Nuclear 
Regulatory Commission, Office of Nuclear Material Safety and 
Safeguards, MS T9F31, Washington, DC, 20555, Telephone (301) 415-7809.

Conduct of the Meetings

    The Diagnostic Sub-Committee meeting will be chaired by Mr. Dennis 
Swanson. Dr. Judith Stitt will chair the Therapeutic Sub-Committee 
meeting. Each sub-committee meeting will be conducted in a manner that 
will facilitate the orderly conduct of business. The following 
procedures apply to public participation in the meetings:
    1. Persons who wish to provide a written statement should submit a 
reproducible copy to Mary Louise Roe (address listed previously), by 
February 19, 1999. Statements must pertain to the topics on the agenda 
for the meeting.
    2. Questions from members of the public will be permitted during 
the meetings at the discretion of the Chairmen.
    3. The meeting summaries and written comments will be available for 
inspection, and copying, for a fee, at the NRC Public Document Room, 
2120 L Street, N.W., Lower Level, Washington, DC 20555, telephone (202) 
634-3273, on or about April 1, 1999.
    4. Seating for the public will be on a first-come, first-served 
basis.
    These meetings will be held in accordance with the Atomic Energy 
Act of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10, U.S. Code of Federal Regulations, Part 7.

    Dated: January 28, 1999.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 99-2512 Filed 2-2-99; 8:45 am]
BILLING CODE 7590-01-P